01:51 PM EDT, 09/25/2025 (MT Newswires) -- Theratechnologies ( THTX ) said Thursday that Future Pak affiliate CB Biotechnology has finalized its acquisition of the company for $3.01 per share in cash plus one contingent value right per share.

The company's shares are set to be delisted from Nasdaq on or about Thursday and from the Toronto Stock Exchange on or about Friday, the company said.

The contingent value right is of up to $1.19 per share if specific milestones are achieved by Theratechnologies ( THTX ), the company said.

Shares were down 0.7% in recent afternoon trading.

Price: 3.37, Change: -0.02, Percent Change: -0.74